Asieris(SH:688176) Zheng Quan Ri Bao·2025-10-29 22:49Core Viewpoint - The company, Jiangsu Yahon Pharmaceutical Technology Co., Ltd., has released its quarterly report, ensuring the accuracy and completeness of the financial information presented, and confirming that there are no false records or misleading statements [2][3]. Financial Data Summary - The financial statements for the third quarter are unaudited, covering the period from the beginning to the end of the quarter [3][8]. - The report includes major accounting data and financial indicators, with all figures presented in Renminbi [3][8]. - The company has a share repurchase account holding 8,667,675 shares, representing 1.52% of total shares [5]. Non-Recurring Gains and Losses - The report indicates that non-recurring gains and losses are applicable, but specific details on significant items are not provided [4]. Shareholder Information - The report does not include information on major shareholders or changes in shareholding due to securities lending [6][7].